GlassScriptPhysician profile
Jessica Pharar
NPI 1659758647
$3,162.91
in general payments reported to CMS, 2019-2025
13 companies · $405 in 2025
The $405 reported for 2025 was more than what 88% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $450 · 2021: $1,519 · 2022: $42.46 · 2023: $168 · 2024: $337 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560 · Education: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.48 |
| Education | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $901.50 | 2020-2021 | |
| Dentsply Sirona INC | $792.42 | 2019-2024 | Primescan Connect, Cavitron |
| Align Technology, INC. | $691.33 | 2020-2025 | Invisalign |
| Sonendo INC | $297.97 | 2019-2021 | |
| Nobel Biocare USA | $183.25 | 2021-2023 | Nobelactive |
| Straumann USA LLC | $116.98 | 2019-2025 | |
| 3m Company | $52.89 | 2021-2023 | 3m Filtek, 3m Relyx, Scotchbond Universal Plus |
| Implant Direct Sybron International LLC | $29.33 | 2022 | |
| Elevate Oral Care | $26.89 | 2022-2023 | Fluorimax 5000, Fluorimax Mint, Advantage Arrest |
| Zimvie INC. | $23.60 | 2023 | |
| Orapharma, A Division of Bausch Health US, LLC | $16.15 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $15.82 | 2024 | Extaro 300 |
| Philips North America LLC | $14.78 | 2025 | Whitening Pens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Pharar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.